Ro
Investors have showered the New York company with $876 million to date.
The health tech company teamed up with New York State's Department of Public Health to distribute the vaccines.
Reuters' reports also highlighted Sharecare's now confirmed acquisition of healthcare AI startup, doc.ai.
Workpath will now integrate into Ro and offer in-home lab services.
This week's top stories include Ro and Hims looking to score significant funding, while the healthcare industry seeks more funds to make up for lost revenue due to the pandemic.
Also: Kore and Dexcom prepare the G6 CGM for remote patient-monitoring; Tyto Care tackles Europe with santé24 integration and deployment.
Customers will now be able to use the services to get eczema treatment, as well as prescription antiperspirant and dandruff shampoo.
The new medications are focused on seasonal allergies.
The new site contains information about sexual health, hair loss, weight management, diabetes, and men's health.